Latest News

International study lays the foundations for potential new therapy of a large number of diseases | Joint press release by the Medical Faculty Mannheim, Heidelberg University and the German Centre for Cardiovascular Research

Environmental stressors such as traffic noise pose a threat to human health worldwide. A study by DZHK researcher Prof. Thomas Münzel, published in the European Journal of Preventive Cardiology, shows that noise has negative effects on blood vessels and the brain within a very...

When the heart gets out of rhythm, characteristic processes occur in the heart muscle cells. Among other things, the currents of electrically charged particles (ions) change. In chronic atrial fibrillation, one of these currents is reduced. Dr. Cristina Molina from the University...

Cardiovascular diseases are the leading cause of death in Germany, accounting for around 40 percent of all deaths. The causes are diverse, and information about them is not readily available to the general public. With the launch of Herzmedizin.de, the German Society of...

Senior Professor at the University of Heidelberg and long-standing spokesman for the DZHK: Prof. Dr. Hugo A. Katus as a pioneer of myocardial infarction diagnostics has been honoured with the highest award of the state of Baden-Württemberg / Further prestigious awards: Carl...

At the German Center for Cardiovascular Research (DZHK), clinical study data and samples belong not to individual clinics but to a superordinate structure - the DZHK. The basis for this is the collaborative clinical research platform launched ten years ago, which makes data and...

Congratulations! At the 89th Annual Meeting of the German Society of Cardiology (DGK), numerous DZHK scientists were honored.

Brown bears as well as paraplegics utilise a mechanism that prevents the formation of blood clots. The discovery is far-reaching and could open up new therapeutic options. Immobilised acute patients could benefit from this. The study results of the international research team led...

The world's only clinical trial to implant artificial heart tissue in patients with heart failure to permanently strengthen the heart muscle has reached its first important milestone: the determination of the maximum safe dose could be completed after the treatment of 10...